Medical Foods Market Synopsis

Medical Foods Market Size is Valued at USD 21.5 Billion in 2023, and is Projected to Reach USD 34.22 Billion by 2032, Growing at a CAGR of 5.3% From 2024-2032.

This type of food product is for patients with specific health conditions or particular diseases because the medical foods are designed to provide special nutrients required for the enfermedad. These are food for special nutritional care with ailments that cannot be controlled with normal diets only. They are taken under prescription and serve to deliver needed nutrients in measured dose, usually with a view to supplement or complement a medical treatment or disease condition.

• This is why the market for medical foods is rapidly expanding at the present time: the frequency of diabetes, cancer, neurological disorders and other severe diseases is growing every year. According to the definition, medical foods are products which are supposed to meet the nutritional needs of patients with certain diseases or other medical ailments, with the guidance of a doctor. With the increase in the population of the elderly and the increasing prevalence of chronic diseases, the need for nutritional products that would cater for patient’s health needs is on the rise. Additional, widespread understanding of medical foods by healthcare providers and patients has also fuelled this market.
• Moreover, novelty in medical nutrition therapy, as well as increasing research and development investments, is positively influencing the product variety of medical foods. There is growing interest of manufacturers to produce products that are customized to suit specific peoples’ needs especially metabolic diseases and gastrointestinal diseases. It is also important to note that the regulatory approaches are being developed to facilitate the utilization of medical foods but a few areas of the world experience difficulties connected with the rigid conformity to the regulatory requirements. With these favorable trends, the market for medical foods is expected to grow significantly in the coming years providing the right opportunity to grow both in developed and the developing world.

Medical Foods Market Trend Analysis

Impact of Metabolic Disorders and Aging Population on the Medical Foods Market

• An important trend that contributes to the growth of the market for medical foods is the growing rate of lifestyle diseases; including diabetes and obesity which have dietary restrictions. With an increasing global prevalence of these ailments, there is increasing market for products such as medical foods that are designed to address nutritional deficiencies of patients. They are antidiabetic, antiobesity, and nutritional products which make it easier for people with metabolic disorders to keep their conditions in check. Demand for these condition-specific diet solutions has also driven innovation in the medical foods having specific value proposition, which has extended the market growth.
• Furthermore, because the world’s population is aging, the interest in medical foods has been found to be greatly impacted. Older patients are prone to contract chronic diseases including cardiac diseases, kidney ailment, and deterioration of brain functions, and certain diets should be provided to avoid exacerbation of conditions. These medical foods have nutritional and pharmacological effects that assist in handling the above mentioned ailments making the lives of the elderly patients better. In particular, the growing incidence of disease-specific nutrition needs of the elderly is projected to become the driving force for medical foods consumption and market growth in the coming years.

Biotechnology and Nutritional Science Advancements Fueling Innovation in Medical Foods

• The trends that are seen currently in the medical foods market are due to advancements made in the field of biotechnology and nutritional science: new product development is most intense in products for neurological disorders, gastrointestinal diseases, and other specific diseases of metabolism.. Over the years as research in these fields took shape, manufacturing firms focused their efforts on the development of these specific medical foods needed in the nutritional management of these diseases. It has pushed manufacturers to the edge as far as research of new products is concerned, leading to functional foods, products that have a specific health benefit over others, for example immunity boosting foods, foods that enhance cognitive abilities, and foods that promote good gut health. The following innovations are not only fitting specific diseases though in fact enriching the concept of medical nutrition therapy.•
• Consumers’ enhanced understanding of nutrition as a means to managing their health is also exerting pressure towards increased utilization of medical foods. development is currently focused on products for neurological disorders, gastrointestinal diseases, and other specific diseases of metabolism. As research in these fields advanced, manufacturing companies turned their attention to development of specific medical foods that address the specific nutrient requirements for individuals with these diseases. It has forced manufacturers to go all out in research of new products resulting into functional foods that provide a particular health benefit, for instance immunity boosters, cognitive enhancers and gut health foods. The following advancements are not only supporting particular medical conditions, but they are also expanding the definition of medical nutrition.

Medical Foods Market Segment Analysis:

Medical Foods Market Segmented based on By Product Type, By Application, By Form and By Distribution Channel

By Product Type, Nutritionally Complete Formulas segment is expected to dominate the market during the forecast period

• They are formulated foods which contain adequate amounts of any nutrient and provide a balanced intake of carbohydrate, proteins, fats, vitamins and minerals. These formulas are essential for people with special medical need to have restricted diet intake and nutrient absorption including gastrointestinal disease, critical illness or post-operative patients. Because they are packed with nutrients in a dense and lightly processed form, these diets provide the patient with energy and protection when intervention does not allow for ordinary consumption. The composition of these formulas is sleek and deliberately designed to provide nutrition for the typical day, and are an essential tool in clinical dietetics.
• In the clinical practice, when using artificial diets, nutritionally complete formulas can be delivered enterally through nasogastric or post-pyloric tubes or orally. It is usually the only food the patents take or the only source of nutrients for patients with severe illnesses such as critical illness, cancers, neurological diseases, or severe malabsorption syndromes. For those patients who are in recovery or, if there is a treatment for which the appetite or ability to digest nutrients is impacted, these formulas allow for proper nutrition without the difficulties associated with consuming solid foods. It is used extensively as it has a fabulously positive effect on the patient because it reduces the risk of malnutrition, promotes early rehab and boosts the body’s immunity to diseases or ability to manage chronic illnesses.

By Distribution Channel, Hospital Pharmacies segment held the largest share in 2023

• Today, hospitals’ pharmacies have their significant role in the patients’ clinical care through provision of medicines and other nutritional products based on patients’ needs. These facilities are designed to address the intricacies the patient needs such as administering specific formulas that are relevant to patient’s health conditions that relate to nutrition. Hospital pharmacists work in conjunction with other health care practitioners when managing patient care plans and the prescription medicine that will the provide patient with a specific diagnosis and treatment regime, nutritional needs. This is acts as a effective model of care delivery and patient recovery.
• On the other hand, retail pharmacies and drug stores/are targeting bulk citizens offering nutritional supplemental foods in form of drugs. These stores are primarily convenience, it is easy for the consumer to find a selection of complete meals, powders, Hunger Bar, and other nutritional supplements and health products without a prescription. Supermarkets also sell OTC drugs in service stores which contain competent pharmacists who assist customers in selecting proper formulations according to diet or other need. This acute / convenient distribution model with hospital pharmacies on the one side and retail outlets on the other side guarantees that everybody gains access to the nutritional support he or she needs if treated in a hospital or if a consumer.

Medical Foods Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• In North America especially, the medical foods market is well developed as a result of advanced healthcare system and increasing consciousness about the effect of nutrients in the disease management. The prevalence of diseases like diabetes, Alzheimer’s, cancer, and metabolic disorders therefore ensures that the medical foods required to meet individual patient needs transpire. Another factor is related to population aging since persons of advanced age compose a large share of patients with complex and requiring specific nutrients to control chronic illnesses. Moreover, due to scientific development in healthcare systems in the United States, medical foods have become an important part of the therapy and treatment process of different diseases for people with individual nutritional needs.
• The United States dominates the North American region, mainly owing to reimbursement policies that enhance the expansion of medical foods in patient healthcare plans. Doctors and dietitians in the country include medical foods into patients recovery plan for case management of diseases that are chronic in nature. Such application is further backed by healthcare facilities and insurance providers who identify with a long-term capacity of medical foods in disease prevention and management, cutting down health costs and enhancing client results. In addition, well developed governmental encouragement of clinical trial and new product development creates favorable conditions for the market development.

Active Key Players in the Medical Foods Market

• Danone S.A. (France)
• Nestlé (Switzerland)
• Abbott (U.S.)
• Primus Pharmaceuticals, Inc. (U.S.)
• Mead Johnson & Company, LLC. (U.S.)
• Medtrition, Inc. (U.S.)
• Fresenius Kabi AG (Germany)
• Meiji Holdings Co., Ltd. (Japan)
• Reckitt Benckiser Group PLC (U.K.)
• Cerecin Inc. (U.S.)
• Metagenics (U.S.)
• ENTERA HEALTHCARE (U.S.)
• Bausch Health Companies Inc. (Canada)
• Upsher-Smith Laboratories, LLC (U.S.)
• Other Key Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Medical Foods Market by Product Type
 4.1 Medical Foods Market Snapshot and Growth Engine
 4.2 Medical Foods Market Overview
 4.3 Nutritionally Complete Formulas
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Nutritionally Complete Formulas: Geographic Segmentation Analysis
 4.4 Nutritionally Incomplete Formulas
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Nutritionally Incomplete Formulas: Geographic Segmentation Analysis
 4.5 Oral Rehydration Products
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Oral Rehydration Products: Geographic Segmentation Analysis

Chapter 5: Medical Foods Market by Application
 5.1 Medical Foods Market Snapshot and Growth Engine
 5.2 Medical Foods Market Overview
 5.3 ADHD
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 ADHD: Geographic Segmentation Analysis
 5.4 Depression
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Depression: Geographic Segmentation Analysis
 5.5 Diabetes
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Diabetes: Geographic Segmentation Analysis
 5.6 Cancer
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Cancer: Geographic Segmentation Analysis
 5.7 Alzheimer's Disease
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Alzheimer's Disease: Geographic Segmentation Analysis
 5.8 Metabolic Disorders
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Metabolic Disorders: Geographic Segmentation Analysis
 5.9 Others
  5.9.1 Introduction and Market Overview
  5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.9.3 Key Market Trends, Growth Factors and Opportunities
  5.9.4 Others: Geographic Segmentation Analysis

Chapter 6: Medical Foods Market by Form
 6.1 Medical Foods Market Snapshot and Growth Engine
 6.2 Medical Foods Market Overview
 6.3 Powders
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Powders: Geographic Segmentation Analysis
 6.4 Liquid
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Liquid: Geographic Segmentation Analysis
 6.5 Capsules
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Capsules: Geographic Segmentation Analysis
 6.6 Tablets
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Tablets: Geographic Segmentation Analysis
 6.7 Bars
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Bars: Geographic Segmentation Analysis

Chapter 7: Medical Foods Market by Distribution Channel
 7.1 Medical Foods Market Snapshot and Growth Engine
 7.2 Medical Foods Market Overview
 7.3 Hospital Pharmacies
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospital Pharmacies: Geographic Segmentation Analysis
 7.4 Retail Pharmacies
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Retail Pharmacies: Geographic Segmentation Analysis
 7.5 Online Pharmacies
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Online Pharmacies: Geographic Segmentation Analysis
 7.6 Drug Stores
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Drug Stores: Geographic Segmentation Analysis
 7.7 Supermarkets
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Supermarkets: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Medical Foods Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions
  
 8.2 DANONE SA (FRANCE)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 NESTLÉ (SWITZERLAND)
 8.4 ABBOTT (US)
 8.5 PRIMUS PHARMACEUTICALS INC (US)
 8.6 MEAD JOHNSON & COMPANY LLC (US)
 8.7 MEDTRITION INC (US)
 8.8 FRESENIUS KABI AG (GERMANY)
 8.9 MEIJI HOLDINGS CO LTD (JAPAN)
 8.10 RECKITT BENCKISER GROUP PLC (UK)
 8.11 CERECIN INC (US)
 8.12 METAGENICS (US)
 8.13 ENTERA HEALTHCARE (US)
 8.14 BAUSCH HEALTH COMPANIES INC (CANADA)
 8.15 UPSHER-SMITH LABORATORIES LLC (US) OTHER KEY PLAYERS

Chapter 9: Global Medical Foods Market By Region
 9.1 Overview
 9.2. North America Medical Foods Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Product Type
  9.2.4.1 Nutritionally Complete Formulas
  9.2.4.2 Nutritionally Incomplete Formulas
  9.2.4.3 Oral Rehydration Products
  9.2.5 Historic and Forecasted Market Size By Application
  9.2.5.1 ADHD
  9.2.5.2 Depression
  9.2.5.3 Diabetes
  9.2.5.4 Cancer
  9.2.5.5 Alzheimer's Disease
  9.2.5.6 Metabolic Disorders
  9.2.5.7 Others
  9.2.6 Historic and Forecasted Market Size By Form
  9.2.6.1 Powders
  9.2.6.2 Liquid
  9.2.6.3 Capsules
  9.2.6.4 Tablets
  9.2.6.5 Bars
  9.2.7 Historic and Forecasted Market Size By Distribution Channel
  9.2.7.1 Hospital Pharmacies
  9.2.7.2 Retail Pharmacies
  9.2.7.3 Online Pharmacies
  9.2.7.4 Drug Stores
  9.2.7.5 Supermarkets
  9.2.8 Historic and Forecast Market Size by Country
  9.2.8.1 US
  9.2.8.2 Canada
  9.2.8.3 Mexico
 9.3. Eastern Europe Medical Foods Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Product Type
  9.3.4.1 Nutritionally Complete Formulas
  9.3.4.2 Nutritionally Incomplete Formulas
  9.3.4.3 Oral Rehydration Products
  9.3.5 Historic and Forecasted Market Size By Application
  9.3.5.1 ADHD
  9.3.5.2 Depression
  9.3.5.3 Diabetes
  9.3.5.4 Cancer
  9.3.5.5 Alzheimer's Disease
  9.3.5.6 Metabolic Disorders
  9.3.5.7 Others
  9.3.6 Historic and Forecasted Market Size By Form
  9.3.6.1 Powders
  9.3.6.2 Liquid
  9.3.6.3 Capsules
  9.3.6.4 Tablets
  9.3.6.5 Bars
  9.3.7 Historic and Forecasted Market Size By Distribution Channel
  9.3.7.1 Hospital Pharmacies
  9.3.7.2 Retail Pharmacies
  9.3.7.3 Online Pharmacies
  9.3.7.4 Drug Stores
  9.3.7.5 Supermarkets
  9.3.8 Historic and Forecast Market Size by Country
  9.3.8.1 Bulgaria
  9.3.8.2 The Czech Republic
  9.3.8.3 Hungary
  9.3.8.4 Poland
  9.3.8.5 Romania
  9.3.8.6 Rest of Eastern Europe
 9.4. Western Europe Medical Foods Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Product Type
  9.4.4.1 Nutritionally Complete Formulas
  9.4.4.2 Nutritionally Incomplete Formulas
  9.4.4.3 Oral Rehydration Products
  9.4.5 Historic and Forecasted Market Size By Application
  9.4.5.1 ADHD
  9.4.5.2 Depression
  9.4.5.3 Diabetes
  9.4.5.4 Cancer
  9.4.5.5 Alzheimer's Disease
  9.4.5.6 Metabolic Disorders
  9.4.5.7 Others
  9.4.6 Historic and Forecasted Market Size By Form
  9.4.6.1 Powders
  9.4.6.2 Liquid
  9.4.6.3 Capsules
  9.4.6.4 Tablets
  9.4.6.5 Bars
  9.4.7 Historic and Forecasted Market Size By Distribution Channel
  9.4.7.1 Hospital Pharmacies
  9.4.7.2 Retail Pharmacies
  9.4.7.3 Online Pharmacies
  9.4.7.4 Drug Stores
  9.4.7.5 Supermarkets
  9.4.8 Historic and Forecast Market Size by Country
  9.4.8.1 Germany
  9.4.8.2 UK
  9.4.8.3 France
  9.4.8.4 Netherlands
  9.4.8.5 Italy
  9.4.8.6 Russia
  9.4.8.7 Spain
  9.4.8.8 Rest of Western Europe
 9.5. Asia Pacific Medical Foods Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Product Type
  9.5.4.1 Nutritionally Complete Formulas
  9.5.4.2 Nutritionally Incomplete Formulas
  9.5.4.3 Oral Rehydration Products
  9.5.5 Historic and Forecasted Market Size By Application
  9.5.5.1 ADHD
  9.5.5.2 Depression
  9.5.5.3 Diabetes
  9.5.5.4 Cancer
  9.5.5.5 Alzheimer's Disease
  9.5.5.6 Metabolic Disorders
  9.5.5.7 Others
  9.5.6 Historic and Forecasted Market Size By Form
  9.5.6.1 Powders
  9.5.6.2 Liquid
  9.5.6.3 Capsules
  9.5.6.4 Tablets
  9.5.6.5 Bars
  9.5.7 Historic and Forecasted Market Size By Distribution Channel
  9.5.7.1 Hospital Pharmacies
  9.5.7.2 Retail Pharmacies
  9.5.7.3 Online Pharmacies
  9.5.7.4 Drug Stores
  9.5.7.5 Supermarkets
  9.5.8 Historic and Forecast Market Size by Country
  9.5.8.1 China
  9.5.8.2 India
  9.5.8.3 Japan
  9.5.8.4 South Korea
  9.5.8.5 Malaysia
  9.5.8.6 Thailand
  9.5.8.7 Vietnam
  9.5.8.8 The Philippines
  9.5.8.9 Australia
  9.5.8.10 New Zealand
  9.5.8.11 Rest of APAC
 9.6. Middle East & Africa Medical Foods Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Product Type
  9.6.4.1 Nutritionally Complete Formulas
  9.6.4.2 Nutritionally Incomplete Formulas
  9.6.4.3 Oral Rehydration Products
  9.6.5 Historic and Forecasted Market Size By Application
  9.6.5.1 ADHD
  9.6.5.2 Depression
  9.6.5.3 Diabetes
  9.6.5.4 Cancer
  9.6.5.5 Alzheimer's Disease
  9.6.5.6 Metabolic Disorders
  9.6.5.7 Others
  9.6.6 Historic and Forecasted Market Size By Form
  9.6.6.1 Powders
  9.6.6.2 Liquid
  9.6.6.3 Capsules
  9.6.6.4 Tablets
  9.6.6.5 Bars
  9.6.7 Historic and Forecasted Market Size By Distribution Channel
  9.6.7.1 Hospital Pharmacies
  9.6.7.2 Retail Pharmacies
  9.6.7.3 Online Pharmacies
  9.6.7.4 Drug Stores
  9.6.7.5 Supermarkets
  9.6.8 Historic and Forecast Market Size by Country
  9.6.8.1 Turkey
  9.6.8.2 Bahrain
  9.6.8.3 Kuwait
  9.6.8.4 Saudi Arabia
  9.6.8.5 Qatar
  9.6.8.6 UAE
  9.6.8.7 Israel
  9.6.8.8 South Africa
 9.7. South America Medical Foods Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Product Type
  9.7.4.1 Nutritionally Complete Formulas
  9.7.4.2 Nutritionally Incomplete Formulas
  9.7.4.3 Oral Rehydration Products
  9.7.5 Historic and Forecasted Market Size By Application
  9.7.5.1 ADHD
  9.7.5.2 Depression
  9.7.5.3 Diabetes
  9.7.5.4 Cancer
  9.7.5.5 Alzheimer's Disease
  9.7.5.6 Metabolic Disorders
  9.7.5.7 Others
  9.7.6 Historic and Forecasted Market Size By Form
  9.7.6.1 Powders
  9.7.6.2 Liquid
  9.7.6.3 Capsules
  9.7.6.4 Tablets
  9.7.6.5 Bars
  9.7.7 Historic and Forecasted Market Size By Distribution Channel
  9.7.7.1 Hospital Pharmacies
  9.7.7.2 Retail Pharmacies
  9.7.7.3 Online Pharmacies
  9.7.7.4 Drug Stores
  9.7.7.5 Supermarkets
  9.7.8 Historic and Forecast Market Size by Country
  9.7.8.1 Brazil
  9.7.8.2 Argentina
  9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research